The IASLC mesothelioma staging project: proposals for the M descriptors and for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM …

Valerie W Rusch, Kari Chansky, Hedy L Kindler, Anna K Nowak, Harvey I Pass, David C Rice, Lynn Shemanski, Françoise Galateau-Sallé, Brian C McCaughan, Takashi Nakano, Enrico Ruffini, Jan P Van Meerbeeck, Masahiro Yoshimura, Peter Goldstraw, Ramón Rami-Porta, Hisao Asamura, David Ball, David Beer, Ricardo Beyruti, Vanessa Bolejack, John Crowley, Frank C Detterbeck, Wilfried Ernst Erich Eberhardt, John Edwards, Dorothy Giroux, Fergus Gleeson, Patti Groome, James Huang, Catherine Kennedy, Jhingook Kim, Young Tae Kim, Laura Kingsbury, Haruhiko Kondo, Mark Krasnik, Kaoru Kubota, Toni Lerut, Gustavo Lyons, Mirella Marino, Edith M Marom, Alan Mitchell, Andrew G Nicholson, Anna Nowak, Michael Peake, Thomas W Rice, Kenneth Rosenzweig, Nagahiro Saijo, Paul Van Schil, Jean-Paul Sculier, Kelly Stratton, Kenji Suzuki, Yuji Tachimori, Charles F Thomas Jr, William D Travis, Ming S Tsao, Andrew Turrisi, Johan Vansteenkiste, Hirokazu Watanabe, Yi-Long Wu, Paul Baas, Jeremy Erasmus, Seiki Hasegawa, Kouki Inai, Kemp Kernstine, Hedy Kindler, Lee Krug, Kristiaan Nackaerts, Harvey Pass, David Rice, Conrad Falkson, Pier Luigi Filosso, Giuseppe Giaccone, Kazuya Kondo, Marco Lucchi, Meinoshin Okumura, Eugene Blackstone, H Asamura, H Batirel, A Bille, U Pastorino, S Call, A Cangir, S Cedres, J Friedberg, F Galateau-Sallé, S Hasagawa, K Kernstine, H Kindler, B McCaughan, T Nakano, A Nowak, C Atinkaya Ozturk, H Pass, M de Perrot, F Rea, D Rice, R Rintoul, E Ruffini, V Rusch, L Spaggiari, D Galetta, K Syrigos, C Thomas, JP van Meerbeeck, P Nafteux, J Vansteenkiste, W Weder, I Optiz, M Yoshimura
2016-12-01
Abstract:IntroductionThe M component and TNM stage groupings for malignant pleural mesothelioma (MPM) have been empirical. The International Association for the Study of Lung Cancer developed a multinational database to propose evidence-based revisions for the eighth edition of the TNM classification of MPM.MethodsData from 29 centers were submitted either electronically or by transfer of existing institutional databases. The M component as it currently stands was validated by confirming sufficient discrimination (by Kaplan-Meier analysis) with respect to overall survival (OS) between the clinical M0 (cM0) and cM1 categories. Candidate stage groups were developed by using a recursive partitioning and amalgamation algorithm applied to all cM0 cases.ResultsOf 3519 submitted cases, 2414 were analyzable and 84 were cM1 cases. Median OS for cM1 cases was 9.7 months versus 13.4 months (p = 0.0013) for …
What problem does this paper attempt to address?